Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients.
Bensmaïne MA, Marty M, de Gramont A, Brienza S, Lévi F, Ducreux M, François E, Gamelin E, Bleiberg H, Cvitkovic E. Bensmaïne MA, et al. Among authors: levi f. Br J Cancer. 2001 Aug 17;85(4):509-17. doi: 10.1054/bjoc.2001.1953. Br J Cancer. 2001. PMID: 11506488 Free PMC article. Clinical Trial.
A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.
Lévi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, Caussanel JP, Kunstlinger F, Lecouturier S, Descorps-Declère A, et al. Lévi F, et al. Cancer. 1992 Feb 15;69(4):893-900. doi: 10.1002/1097-0142(19920215)69:4<893::aid-cncr2820690410>3.0.co;2-x. Cancer. 1992. PMID: 1735081 Clinical Trial.
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L, et al. Lévi FA, et al. J Natl Cancer Inst. 1994 Nov 2;86(21):1608-17. doi: 10.1093/jnci/86.21.1608. J Natl Cancer Inst. 1994. PMID: 7932825 Clinical Trial.
Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer.
Metzger G, Massari C, Etienne MC, Comisso M, Brienza S, Touitou Y, Milano G, Bastian G, Misset JL, Lévi F. Metzger G, et al. Among authors: levi f. Clin Pharmacol Ther. 1994 Aug;56(2):190-201. doi: 10.1038/clpt.1994.123. Clin Pharmacol Ther. 1994. PMID: 8062496 Clinical Trial.
Implications of chronobiology for 5-fluorouracil (5-FU) efficacy.
Lévi F, Brienza S, Metzer G, Deprés-Brummer P, Bertheault-Cvitkovic F, Zidani R, Adam R, Misset JL. Lévi F, et al. Adv Exp Med Biol. 1993;339:169-83. doi: 10.1007/978-1-4615-2488-5_18. Adv Exp Med Biol. 1993. PMID: 8178715 Review. No abstract available.
962 results